Period Ending | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
---|
Total Revenue
|
13,286,000
|
13,093,000
|
14,688,000
|
13,226,000
| Cost of Revenue | 8,416,000 | 8,426,000 | 9,795,000 | 8,611,000 | |
Gross Profit
|
4,870,000
|
4,667,000
|
4,893,000
|
4,615,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 2,854,000 | 2,822,000 | 3,333,000 | 2,866,000 |
|
Non Recurring | 84,000 | 98,000 |
-
| (7,000) |
|
Others | 53,000 | 56,000 | 53,000 | 58,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,879,000
|
1,691,000
|
1,507,000
|
1,698,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,879,000 | 1,691,000 | 934,000 | 386,000 |
|
Interest Expense | 429,000 | 553,000 |
-
| (887,000) |
|
Income Before Tax | 1,450,000 | 1,138,000 | 934,000 | 1,273,000 |
|
Income Tax Expense | 416,000 | 319,000 | 92,000 | 346,000 |
|
Minority Interest | (5,000) | (6,000) | (12,000) | (5,000) |
|
|
|
Net Income From Continuing Ops | 1,029,000 | 813,000 | 842,000 | 930,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,029,000
|
813,000
|
830,000
|
922,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,029,000
|
813,000
|
830,000
|
922,000
|
|